Abbott Diabetes Care Inc.

Abbott Diabetes Care Inc. is a subsidiary of Abbott Laboratories, a global healthcare company founded in 1888. Abbott Diabetes Care is headquartered in Alameda, California, with additional significant operations in other global locations. Abbott Laboratories, its parent company, reported total sales of $44.3 billion in 2025 and employs approximately 114,000 people worldwide.

Abbott Diabetes Care focuses on the design, development, manufacture, and distribution of glucose monitoring devices and related tools for people with diabetes and healthcare professionals. Their major product lines include continuous glucose monitoring (CGM) systems, such as the FreeStyle Libre portfolio, and traditional blood glucose monitoring systems like the FreeStyle Navigator, FreeStyle Lite, FreeStyle Freedom Lite, and Precision Xtra systems. These products aim to make blood glucose monitoring easier, less uncomfortable, and provide faster results.

Abbott Diabetes Care has appeared in our database as a plaintiff in one tracked case. This indicates a posture of actively asserting its intellectual property rights. The single case, Abbott Diabetes Care Inc. v. Dexcom, Inc., was filed in the United States District Court for the District of Delaware in 2019.

The company's litigation activity against Dexcom, Inc. suggests a focus on protecting its innovations within the competitive continuous glucose monitoring market. This aligns with Abbott's broader commitment to advancing diabetes technology through ongoing research and development.